Deepak Bararia

736 total citations
17 papers, 446 citations indexed

About

Deepak Bararia is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Deepak Bararia has authored 17 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Deepak Bararia's work include Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Deepak Bararia is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Deepak Bararia collaborates with scholars based in Germany, United States and Singapore. Deepak Bararia's co-authors include Daniel G. Tenen, Robert S. Welner, Henry Yang, Wolfgang Hiddemann, Gerhard Behre, Elena Levantini, Arun Kumar Trivedi, Vas Dev, Ashwani Kumar and Sumiti Vinayak and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Deepak Bararia

16 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deepak Bararia Germany	11	206	146	99	84	78	17	446
Yin Tong China	15	325 1.6×	145 1.0×	49 0.5×	96 1.1×	203 2.6×	45	603
Isabel Boivin Canada	12	302 1.5×	268 1.8×	39 0.4×	61 0.7×	68 0.9×	20	536
Samantha Bruno Italy	13	228 1.1×	85 0.6×	22 0.2×	47 0.6×	67 0.9×	40	417
Shihan He United States	8	569 2.8×	230 1.6×	26 0.3×	43 0.5×	84 1.1×	15	702
Maria L. Amaya United States	10	517 2.5×	287 2.0×	68 0.7×	55 0.7×	71 0.9×	30	750
Cindy S. Luo Australia	9	343 1.7×	38 0.3×	39 0.4×	151 1.8×	152 1.9×	10	535
V Ruppert Germany	10	308 1.5×	205 1.4×	176 1.8×	130 1.5×	205 2.6×	13	552
Robyn L. Schenk Australia	9	277 1.3×	30 0.2×	57 0.6×	149 1.8×	154 2.0×	14	495
Angela Hu United States	11	258 1.3×	39 0.3×	31 0.3×	79 0.9×	139 1.8×	23	470
S. Srimatkandada United States	11	305 1.5×	57 0.4×	126 1.3×	34 0.4×	165 2.1×	15	521

Countries citing papers authored by Deepak Bararia

Since Specialization

Citations

This map shows the geographic impact of Deepak Bararia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Bararia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Bararia more than expected).

Fields of papers citing papers by Deepak Bararia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Bararia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Bararia. The network helps show where Deepak Bararia may publish in the future.

Co-authorship network of co-authors of Deepak Bararia

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Bararia. A scholar is included among the top collaborators of Deepak Bararia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Bararia. Deepak Bararia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Akanuma, Naoki, Ikei S. Kobayashi, Eunyoung Heo, et al.. (2023). TIP60 is required for tumorigenesis in non‐small cell lung cancer. Cancer Science. 114(6). 2400–2413. 14 indexed citations

Krüger, Stephan, Volker Heinemann, Deepak Bararia, et al.. (2021). Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel. Clinical & Translational Oncology. 23(11). 2394–2401. 13 indexed citations

Haebe, Sarah, Stefan Alig, Michael Heide, et al.. (2021). The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. British Journal of Haematology. 196(6). 1381–1387. 5 indexed citations

Bararia, Deepak, Michael Heide, Verena Passerini, et al.. (2021). ARID1A Controls a Novel Transcriptional Network Regulating FAS in Follicular Lymphoma. Blood. 138(Supplement 1). 3492–3492.

Welner, Robert S., Deepak Bararia, Elena Levantini, et al.. (2020). PU.1 mediates hematopoietic stem cell self-renewal during cellular stress by non-canonical Wnt signaling. The Journal of Immunology. 204(1_Supplement). 223.6–223.6. 1 indexed citations

Numata, Akihiko, Hui Si Kwok, Akira Kawasaki, et al.. (2018). The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia. Nature Communications. 9(1). 1622–1622. 21 indexed citations

Passerini, Verena, Michael Boesl, Michael Heide, et al.. (2018). PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma. Blood. 132(Supplement 1). 2842–2842. 1 indexed citations

Bararia, Deepak, Hui Si Kwok, Robert S. Welner, et al.. (2016). Acetylation of C/EBPα inhibits its granulopoietic function. Nature Communications. 7(1). 10968–10968. 40 indexed citations

Jacobson, Caron A., Nadja Kopp, Jacob V. Layer, et al.. (2016). HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood. 128(21). 2517–2526. 30 indexed citations

10.

Bararia, Deepak, Michael Heide, Robert S. Welner, et al.. (2015). Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy. Blood. 126(23). 571–571. 2 indexed citations

11.

Welner, Robert S., Giovanni Amabile, Deepak Bararia, et al.. (2015). Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells. Cancer Cell. 27(5). 671–681. 97 indexed citations

12.

Bararia, Deepak, Alessandro Pastore, German Ott, et al.. (2015). STAT6 Is Recurrently and Significantly Mutated in Follicular Lymphoma and Enhances the IL-4 Induced Expression of Membrane-Bound and Soluble CD23. Blood. 126(23). 3923–3923. 3 indexed citations

13.

Welner, Robert S., Deepak Bararia, Giovanni Amabile, et al.. (2013). C/EBPα is required for development of dendritic cell progenitors. Blood. 121(20). 4073–4081. 30 indexed citations

14.

Bararia, Deepak, Arun Kumar Trivedi, Philipp A. Greif, et al.. (2008). Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPα. Leukemia. 22(4). 800–807. 35 indexed citations

15.

Pulikkan, John Anto, Deepak Bararia, Arun Kumar Trivedi, et al.. (2006). Proteomic discovery of Max as a novel interacting partner of C/EBPα: a Myc/Max/Mad link. Leukemia. 20(12). 2137–2146. 23 indexed citations

16.

Trivedi, Arun Kumar, Deepak Bararia, Maximilian Christopeit, et al.. (2006). Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPα by inhibiting its ubiquitination. Oncogene. 26(12). 1789–1801. 44 indexed citations

17.

Ahmed, Anwar, Deepak Bararia, Sumiti Vinayak, et al.. (2004). Plasmodium falciparum Isolates in India Exhibit a Progressive Increase in Mutations Associated with Sulfadoxine-Pyrimethamine Resistance. Antimicrobial Agents and Chemotherapy. 48(3). 879–889. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact